TROPHY - Candesartan Cilexetil Long-term Hypertension Prevention Trial

PHASE3CompletedINTERVENTIONAL
Enrollment

1,000

Participants

Timeline

Start Date

July 31, 1998

Primary Completion Date

October 31, 2005

Study Completion Date

October 31, 2005

Conditions
Hypertension
Interventions
DRUG

ATACAND

Trial Locations (42)

Unknown

Research Site, Mobile

Research Site, Long Beach

Research Site, Redondo Beach

Research Site, Santa Ana

Research Site, Tustin

Research Site, Wilmington

Research Site, Washington D.C.

Research Site, Bay Pines

Research Site, Gainsville

Research Site, Ocala

Research Site, Chicago

Research Site, Shawnee Mission

Research Site, Chelsea

Research Site, Detroit

Research Site, Minneapolis

Research Site, Jackson

Research Site, Florissant

Research Site, Kansas City

Research Site, St Louis

Research Site, Buffalo

Research Site, Rochester

Research Site, Williamsville

Research Site, Asheville

Research Site, Chapel Hill

Research Site, Winston-Salem

Research Site, Fargo

Research Site, Canton

Research Site, Cleveland

Research Site, Columbus

Research Site, Oklahoma City

Research Site, Allentown

Research Site, Fleetwood

Research Site, Pittsburgh

Research Site, Providence

Research Site, Warwick

Research Site, Charleston

Research Site, Memphis

Research Site, Dallas

Research Site, Houston

Research Site, Richmond

Research Site, Morgantown

Research Site, Milwaukee

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY